Brind.

Grail was formed following a spin-off from Illumina, and Morgan Stanley reiterated its 'Equal Weight' stance on the companies.

3 reports, 0 independent Updated Jul 9

Gone quiet

Reports: 3
Developments: 1
Repetition: 67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Grail was formed following a spin-off from Illumina, and Morgan Stanley reiterated its 'Equal Weight' stance on the companies.

Who's involved

What this event is mainly about

GRAIL Illumina Morgan Stanley

Keep exploring

The entities involved

GRAIL
American biotechnology and pharmaceutical company
- A lawsuit was filed against GRAIL in the Northern District of California.Mon 01:43
- A lawsuit was filed in New York City involving the company GRAIL.Sun 23:51
Illumina
American company that develops systems for the analysis of genetic variation
- Analysis suggests that both Moderna and Illumina stocks are currently overvalued.Wed 13:01
Morgan Stanley
U.S. investment bank
- Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
- Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24

Coverage

Newest first; wire copies grouped

Jul 9Unknown outlet
Jul 2Unknown outlet
Jun 25Unknown outlet